Pancragen 20 mg

INFORMATION:

• The product (substance) is not a food or dietary supplement, not suitable for human consumption.
• Keep out of the reach of children.
• Keep the container tightly closed.
• Store in a dry, cool, shaded place; protect from moisture.
• Store only in the original container.
• Avoid contact during pregnancy and breastfeeding.
• Consult a physician in case of ill health or adverse reactions related to contact with the substance.

Pancragen is a naturally occurring tetrapeptide bioregulator that has been investigated in experimental literature in relation to pancreas-associated cellular signalling and endocrine-related research models. Pancragen has been described in research contexts as being associated with changes in selected metabolic and endocrine biomarkers in controlled experimental settings. No clinical use, disease treatment, or human-consumption relevance is implied.

Further discussions around Pancragen often focus on interactions between endocrine rhythms and metabolic signalling. Studies describe age-associated metabolic changes as being linked to circadian signalling pathways, including melatonin-related mechanisms, and explore how pancreas-derived signals may interact with broader hormonal regulation. In this context, Pancragen has been evaluated for its potential to modulate pancreas-related signalling readouts in experimental systems.

In experimental literature, melatonin receptors are discussed in relation to pancreas signalling, where they may modulate insulin- and glucagon-related pathways in a diurnal manner. Research also explores potential feedback relationships between endocrine signalling and circadian regulation, including in models that examine metabolic dysregulation. Pancragen has been mentioned in this body of research as a peptide of interest for studying pancreas–circadian cross-talk using measurable laboratory endpoints.

Some studies have compared Pancragen against reference compounds in preclinical settings, focusing on changes in laboratory biomarkers such as plasma glucose, insulin-related markers and peptide co-secretion readouts (e.g., C-peptide) under defined protocols.

A separate line of investigation explores microvascular biology and endothelial behaviour under conditions of metabolic stress in experimental systems. In this area, Pancragen has been discussed in relation to endothelial adhesion and capillary-associated readouts in laboratory models.

Pancragen is not a food or dietary supplement and is not suitable for human consumption. No dosing, administration routes, or human-use directions are provided.

https://pubmed.ncbi.nlm.nih.gov/21246099/

https://pubmed.ncbi.nlm.nih.gov/25946840/

https://pubmed.ncbi.nlm.nih.gov/18642713/